Table 3.
Multiple linear regressions with duration of readmissions and total daily dose or number of medications after adjustments with covariates.
| Duration of readmissions |
||||||
|---|---|---|---|---|---|---|
| Variables | β (×10−2) | 95% CI (×10−2) | P value | β (×10−2) | 95% CI (×10−2) | P value |
| Total daily dose | 7.33 | 0.71, 13.94 | 0.03 | NA | NA | NA |
| Number of medications | NA | NA | NA | 14.87 | 2.26, 27.47 | 0.021 |
| Age (more than 75 year-old) | 154.77 | 40.43, 269.11 | 0.008 | 153.03 | 38.67, 267.40 | 0.009 |
| Racea | ||||||
| If Malay | −151.23 | −290.32, −12.13 | 0.033 | −146.87 | −285.75, −7.98 | 0.038 |
| If Indian | −104.62 | −270.23, 61.00 | 0.215 | −106.48 | −272.02, 59.06 | 0.207 |
| If others | −261.74 | −452.73, −70.74 | 0.007 | −264.99 | −455.96, −74.02 | 0.007 |
| Genderb | ||||||
| If female | 91.54 | −14.71, 197.78 | 0.091 | 89.68 | −16.58, 195.94 | 0.098 |
| Co-morbiditiesc | ||||||
| HTN | 95.15 | −27.62, 217.93 | 0.129 | 82.5 | −41.62, 206.62 | 0.192 |
| HLD | 13.25 | −102.44, 128.94 | 0.822 | 6.6 | −109.57, 122.76 | 0.911 |
| CKD | 161.29 | −0.72, 323.30 | 0.051 | 157.08 | −5.19, 319.35 | 0.058 |
| Depression | 215.51 | 19.90, 411.12 | 0.031 | 219.51 | 24.16, 414.86 | 0.028 |
| Types of DRPd | ||||||
| Supratherapeutic dose | 292.26 | −246.23, 830.74 | 0.287 | 268.88 | −270.31, 808.07 | 0.328 |
| Thrombocytopenia | 755.48 | 84.25, 1426.71 | 0.027 | 752.6 | 81.70, 1423.51 | 0.028 |
Abbreviations: Drug-related problem (DRP).
a
Chinese as reference group.
b
Male as reference group.
c
Absence of comorbidities as reference group.
d
Absence of DRP as reference group.